|
|
|
|
| LEADER |
02897nam a22003975i 4500 |
| 001 |
978-1-59745-562-6 |
| 005 |
20191028203013.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100715s2009 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781597455626
|
| 024 |
7 |
|
|a 10.1007/978-1-59745-562-6
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Neuroproteomics
|b Methods and Protocols /
|c edited by Andrew K. Ottens, Kevin K.W. Wang.
|
| 250 |
|
|
|a 1st ed. 2009.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2009.
|
| 300 |
|
|
|a XI, 321 p. 51 illus.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 566
|
| 505 |
0 |
|
|a Disease Models in Neuroproteomics -- The Methodology of Neuroproteomics -- Modeling Cerebral Ischemia in Neuroproteomics -- Clinical and Model Research of Neurotrauma -- Neuroproteomic Methods in Spinal Cord Injury -- Modeling Substance Abuse for Applications in Proteomics -- Protein Aggregate Characterization in Models of Neurodegenerative Disease -- Sub-Proteome Separations and Neuroproteomic Analysis -- Sub-Proteome Processing: Isolation of Neuromelanin Granules from the Human Bra -- Proteomic Analysis of Protein Phosphorylation and Ubiquitination in Alzheimer’s Disease -- Proteomics Identification of Carbonylated and HNE-Bound Brain Proteins in Alzheimer’s Disease -- Mass Spectrometric Identification of In Vivo Nitrotyrosine Sites in the Human Pituitary Tumor Proteome -- Improved Enrichment and Proteomic Analysis of Brain Proteins with Signaling Function by Heparin Chromatography -- Calmodulin-Binding Proteome in the Bra -- Neuroproteomic Methodology and Bioinformatics -- Separation of the Neuroproteome by Ion Exchange Chromatography -- iTRAQ-Based Shotgun Neuroproteomics -- Methods in Drug Abuse Neuroproteomics: Methamphetamine Psychoproteome -- Shotgun Protein Identification and Quantification by Mass Spectrometry in Neuroproteomics -- Biofluid Analysis and Clinical Translation -- Identification of Glycoproteins in Human Cerebrospinal Fluid -- Mass Spectrometric Analysis of Body Fluids for Biomarker Discovery -- Traumatic Brain Injury Biomarkers: From Pipeline to Diagnostic Assay Development -- Translation of Neurological Biomarkers to Clinically Relevant Platforms.
|
| 650 |
|
0 |
|a Neurology .
|
| 650 |
|
0 |
|a Neurobiology.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Human physiology.
|
| 650 |
|
0 |
|a Cell physiology.
|
| 650 |
1 |
4 |
|a Neurology.
|
| 650 |
2 |
4 |
|a Neurobiology.
|
| 650 |
2 |
4 |
|a Neurosciences.
|
| 650 |
2 |
4 |
|a Human Physiology.
|
| 650 |
2 |
4 |
|a Cell Physiology.
|
| 700 |
1 |
|
|a Ottens, Andrew K.
|e editor.
|
| 700 |
1 |
|
|a Wang, Kevin K.W.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-59745-562-6
|